202-780-5153 info@nidellaw.com
Drug manufacturers make billions of dollars of profit each year despite the fact that prescription drugs are responsible for thousands of injuries each year. Drug makers have a duty to disclose known risks as well as risks they should know about. These risks include those that the drug companies should have known about through adequate testing and safety surveillance on patients taking their drugs.

If you feel that you have been injured by a prescription drug or medical device, please contact us for a free legal consultation to see if you may have a case.

Fosamax

Fosamax, also called alendronate sodium, as well as other drugs in the class of bisphosphonate drugs used to treat osteoporosis and osteopenia have been found to cause bone damage.

Pradaxa

Pradaxa (dabigatran) is a prescription blood-thinning medication approved by the Food and Drug Administration (“FDA”) to reduce the risk of stroke in people with non-valvular atrial fibrillation.

Ortho-Evra

The Associated Press revealed in July of 2005 that the risk of suffering from a blood clot while using the Ortho Evra birth control patch was three times higher than when using standard birth control pills.

SSRIs & Zoloft

The use of the prescription drug Zoloft has been linked to numerous birth defects, injuries, and other complications, particularly when used by pregnant women during their first trimester.

Denture Creams

Millions of Americans use denture creams to keep their dentures securely in place. Zinc, contained in a number of popular adhesive creams, can cause copper deficiency in the user.

Singulair

The FDA updated the Adverse Reactions section of the labeling for Singulair (Montelukast) in September 2012 to include Stevens-Johnson Syndrome (SJS).

Yaz

Yaz is one of the brand names used for the generic drug drospirenone, also sold under the names Yasmine and Ocella.

Procrit, Aranesp, Epogen

According to the FDA, the anemia drugs, Procrit, Epogen, and Aranesp are associated with increased rates of death, heart attack, stroke, and blood clots.
Pradaxa to undergo new FDA safety study

Pradaxa to undergo new FDA safety study

The FDA, amid growing concerns about the risk of uncontrolled bleeding when taking Pradaxa, has determined that an additional comprehensive study of the drug is necessary to determine its safety in comparison with warfarin. See FDA's statement at the following....

read more

Contact an Attorney for a Free Consultation

[]
1 Step 1


Let us know how we can help.
Consultations are always FREE.
Full Name
Phoneincluding area code
Reason for contacting us
0 /
Previous
Next